Fludarabine Phosphate
- Product NDC
- 61703-344
- 11-digit product format
- 617030344
- Labeler code
- 61703
- Product ID
- 61703-344_d8d787fa-bd3e-424d-8abb-73e94aced4dc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- FLUDARABINE PHOSPHATE
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Hospira, Inc.
- Application
- ANDA077790
- Marketing category
- ANDA
- Marketing start
- 2008-09-25
- Marketing end
- 2021-09-30
- Substance
- FLUDARABINE PHOSPHATE
- Active strength
- 50 mg/2mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61703-344-18 | 61703034418 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-344-18) > 2 mL in 1 VIAL, SINGLE-DOSE | 2008-09-25 | 2021-09-30 | No | No | Current |